Finch Therapeutics Group Inc (FNCH)
12.12
+0.17
(+1.45%)
USD |
OTCM |
Nov 05, 14:06
Finch Therapeutics Group Total Liabilities (Quarterly): 31.36M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 31.36M |
| March 31, 2024 | 31.05M |
| December 31, 2023 | 32.49M |
| September 30, 2023 | 33.68M |
| June 30, 2023 | 38.96M |
| March 31, 2023 | 46.09M |
| December 31, 2022 | 67.23M |
| September 30, 2022 | 67.10M |
| Date | Value |
|---|---|
| June 30, 2022 | 69.21M |
| March 31, 2022 | 24.84M |
| December 31, 2021 | 23.14M |
| September 30, 2021 | 13.18M |
| June 30, 2021 | 22.14M |
| March 31, 2021 | 26.49M |
| December 31, 2020 | 261.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.18M
Minimum
Sep 2021
261.06M
Maximum
Dec 2020
52.53M
Average
32.49M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.58M |
| Shareholders Equity (Quarterly) | 14.22M |